Study of Hundreds of Young Adults Finds No Significant Difference in Arterial Stiffness …
#72 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
In a randomized clinical trial, low-THC full-spectrum cannabis extract was found to significantly improve symptoms of autism in children, with no significant difference observed in arterial stiffness among young adults, potentially suggesting a potential therapeutic benefit for autistic children and the need for further research into cannabis-based treatments for autism spectrum disorders. The practical takeaway is that clinicians may consider low-THC full-spectrum cannabis extract as a potential treatment option for managing symptoms of autism in children, while monitoring for any cardiovascular effects.
💊 🧠 A recent study published in The Marijuana Herald reports a significant improvement in autism symptoms among children using low-THC full-spectrum cannabis extract. However, it’s crucial to acknowledge the complexity of this finding, as the sample size was relatively small and the long-term effects remain unclear. In clinical practice, while these results are promising, healthcare providers should exercise caution when considering cannabis as a treatment option for autism due to potential confounders such as other medications, comorbidities, and individual responses to cannabinoids. A practical implication is that further research with larger sample sizes and longer follow-ups is needed to confirm these findings and guide evidence-based clinical decision-making in the management of autism spectrum disorders.
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: